Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hodgkin Disease × Health Promotion × 1 year × Clear all

Sponsor

Conditions

Lung Neoplasms 4 Breast Neoplasms 4 Hematopoietic and Lymphatic System Neoplasm 3 Uterine Cervical Neoplasms 2 Hematologic Neoplasms 2 Colorectal Neoplasms 2 Uveal Melanoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Obesity-Related Malignant Neoplasm 1 Neoplastic Syndromes, Hereditary 1 Malignant Solid Neoplasm 1 Hematopoietic and Lymphoid System Neoplasm 1 HIV Infections 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Cigarette Smoking-Related Carcinoma 1 Breast Cancer, Familial 1 Advanced Malignant Solid Neoplasm 1

Interventions

Cyclophosphamide 31 Doxorubicin 20 pembrolizumab 19 fludarabine 18 Nivolumab 18 fludarabine phosphate 16 Vinblastine 16 Dacarbazine 16 Brentuximab Vedotin 16 Whole-Body Irradiation 15 Mycophenolic Acid 15 Etoposide 13 Melphalan 12 Filgrastim 11 Tacrolimus 10 Gemcitabine 10 Bleomycin 9 Rituximab 8 Radiotherapy 8 Granulocyte Colony-Stimulating Factor 8 Vincristine 7 Prednisone 7 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 pegfilgrastim 6 Stem Cell Transplantation 6 Magnetic Resonance Spectroscopy 6 Bendamustine Hydrochloride 6 Thiotepa 5 Specimen Handling 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡